1. Core Defenses in Danish Medical Device Product Liability

Under Danish law, once a claimant proves:

• defect
• damage (personal injury)
• causal link

the producer is generally strictly liable.

However, manufacturers commonly rely on these defenses:

A. “No defect at time of circulation”

If the device was safe when marketed and later became defective.

B. “Development risk / state of scientific knowledge defense”

Also called “state of the art defense” (Directive Article 7(e)):

• defect could not be discovered with existing scientific knowledge

C. “No causal link”

Most important practical defense in medical device cases.

D. “Misuse / abnormal use”

Device used outside intended medical indication or instructions.

E. “Intervening act by medical professionals”

Error in surgery or hospital handling breaks causation.

F. “Not put into circulation”

Especially relevant in hospital-manufactured or intra-hospital devices.

G. “Public authority / mandatory regulation compliance”

Device complied fully with regulatory requirements.

2. Key Case Law (EU + Danish References Applied in Denmark)

Case 1: Veedfald v Århus Amtskommune (C-203/99, ECJ 2001)

Facts

• Kidney transplant case in a Danish public hospital
• Perfusion fluid used during organ preparation was defective
• Kidney became unusable

Legal issue

Whether a product used inside a hospital counts as:

• “put into circulation”
• “economic activity product”

Judgment

The ECJ held:

• A product used in medical treatment is “put into circulation” even inside a hospital
• Public funding does NOT remove product liability rules

Defense impact

Hospitals tried to argue:

• “no commercial circulation”
• “public healthcare exemption”

Both rejected.

Importance for defenses

This case narrows two key defenses:

• ❌ “not placed on market”
• ❌ “non-economic public service exclusion”

👉 Result: Hospitals and device producers cannot escape liability just because use is clinical.

Case 2: Boston Scientific Medizintechnik (C-503/13 & C-504/13, ECJ 2015)

Facts

• Pacemakers and implantable defibrillators
• Certain production batches had elevated failure risk
• No need to prove individual device defect

Legal issue

Whether a risk of failure alone can establish defect.

Judgment

ECJ ruled:

• Entire product series may be considered defective
• Patients do NOT need to prove actual failure in their device
• If risk is abnormal → defect exists

Defense impact

Manufacturers lost key defenses:

• ❌ “individual device was not defective”
• ❌ “no actual malfunction occurred”
• ❌ “claimant must prove specific defect”

However, allowed defenses still include:

• development risk defense (limited)
• causation arguments for damages beyond replacement

Case 3: Danish Supreme Court – Pharmaceutical Product Liability (DLA Piper referenced case)

Facts (summarized from Danish litigation practice)

• Pharmaceutical product alleged to have caused injury
• Claimant argued defect in design
• Manufacturer relied heavily on scientific uncertainty defense

Judgment trend (important principle)

Danish Supreme Court accepted:

• no liability where scientific/technical knowledge at time could not reveal defect

Defense established:

✔ “state of scientific knowledge” defense successfully applied

Importance

This is one of the strongest defenses in Denmark for medical devices/pharma:

• If risk was unknowable → no liability

Case 4: Danish Hospital-Related Liability Line (Veedfald follow-up jurisprudence)

Facts (pattern in Danish courts)

• Medical device or hospital-prepared product defective
• Patient injury during treatment
• Defendant argues treatment error rather than product defect

Court approach

Danish courts often separate:

• product defect liability (strict)
  vs
• medical negligence (culpa-based)

Defense used:

✔ “medical intervention broke causation chain”

Example reasoning:

• device was fine
• injury caused by surgical misuse or hospital error

Importance

This creates a strong causation defense zone for manufacturers.

Case 5: “Development Risk Defense” in EU medical device litigation (applied in Denmark)

Facts (general EU-aligned Danish cases)

• implant or diagnostic device later found unsafe
• defect was scientifically undiscoverable at time of sale

Rule applied

Article 7(e) of Directive 85/374:
Manufacturer not liable if:

• state of scientific knowledge could not detect defect

Defense effect

✔ Fully absolves liability if proven

Courts require proof that:

• global scientific knowledge was insufficient (not just company knowledge)

Case 6: Danish Case Law on “No Causation” in Device Injury Claims

Facts pattern

• patient injured after implant procedure
• device allegedly defective
• but multiple medical risk factors present

Defense argument

• injury caused by:
  • patient condition
  • surgical complication
  • unrelated disease progression

Court approach

Danish courts often:

• require strong expert medical evidence for causation
• reject liability where causation is uncertain

Key defense strength:

✔ “uncertain causation defeats claim”

Case 7: Intermediary / Hospital Handling Defense Cases (Denmark practice)

Facts

• Device supplied correctly
• hospital storage/handling error or incorrect implantation

Defense

Manufacturer argues:

• product left control safely
• damage occurred after supply chain

Court response

Often:

• liability shifts to hospital or breaks chain entirely

Key defense:

✔ “post-market intervention breaks liability chain”

3. How These Defenses Work Together (Medical Device Reality)

In Denmark, medical device manufacturers usually win or reduce liability using a combined defense strategy:

Step 1: Attack defect definition

• no defect at time of circulation
• or development risk defense

Step 2: Attack causation

• surgical error
• patient condition
• hospital misuse

Step 3: Regulatory compliance defense

• device met EU medical device standards

Step 4: Shift liability

• toward hospital or healthcare provider

4. Key Takeaways (Danish Medical Device Liability Defense Logic)

1. Denmark applies strict liability but heavy causation filtering
2. Biggest defense: state of scientific knowledge
3. Strong ECJ influence limits “public hospital” immunity
4. Medical devices can be “defective in series” (Boston Scientific rule)
5. Most cases turn on causation, not defect